Rubens R D
Division of Oncology, United Medical School, Guy's Hospital, London, U.K.
Eur J Cancer. 1990;26(10):1023-5. doi: 10.1016/0277-5379(90)90041-q.
A detailed approach to the gathering of information on the cost-effectiveness of palliative chemotherapy for patients with cancer has been described. The measures are qualitative and so difficult to study scientifically, but several innovations have been incorporated into the programme which should ensure a level of robustness to give reliable and valid information. Making judgements about the usefulness of treatment for patients involves comparing factors that are inherently incomparable and measuring those which are inherently unmeasurable. Nevertheless, it is hoped that this will be found to be a pessimistic view of what can be achieved by audit, particularly in the light of advances that have been made in assessing quality of life. At the least, the project will provide important statistical information and the existence of the audit process itself should enhance significantly standards of medical practice.
已经描述了一种收集癌症患者姑息化疗成本效益信息的详细方法。这些措施是定性的，因此很难进行科学研究，但该方案纳入了一些创新措施，应能确保一定程度的稳健性，以提供可靠和有效的信息。对患者治疗的有用性进行判断涉及比较本质上不可比的因素，并衡量本质上不可测量的因素。然而，希望这将被证明是对审计所能取得成果的一种悲观看法，特别是鉴于在评估生活质量方面已经取得的进展。至少，该项目将提供重要的统计信息，而且审计过程本身的存在应能显著提高医疗实践标准。
